Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.

Diagnosis, Dual (Psychiatry) Clinical Trial

Official title:

Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05115266
• Other study ID #: AAT BPD&A
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 30, 2022
• Est. completion date: April 30, 2025

Study information

• Verified date: October 2021
• Source: Cardenal Herrera University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the effectiveness of an AAT program in patients diagnosed with borderline personality disorder and substance abuse disorder.

Our hypotheses are that participation in the TAA program will reduce negative symptoms, improve the quality of life of people with dual pathology, whose mental illness is schizophrenia, and increase adherence to treatment for people with dual pathology, whose mental disorder it's schizophrenia.

Description:

Animal assisted therapy (AAT) is a complementary intervention to therapy that presents positive results in the treatment of different pathologies. The study assesses the implementation and effectiveness of a TAA program in patients diagnosed with borderline personality disorder and substance abuse disorder.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: April 30, 2025
• Est. primary completion date: April 30, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Meeting DSM-5 criteria for substance abuse disorder and the presence of borderline personality disorder.

• Voluntary participant in the study and having signed the informed consent

Exclusion Criteria:

• Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier)

• Animal-specific phobia

Related Conditions & MeSH terms

• Borderline Personality Disorder
• Diagnosis, Dual (Psychiatry)
• Personality Disorders

Intervention

Behavioral:
• Animal-assisted therapy (AAT
The activity program consists of 10 sessions with a duration of about 60 minutes. During the 10 sessions the animal is presented, in this case a dog. They caress it, dress it, educate it ...
• Usual treatment
receive usual treatment (group activities)

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Miguel Monfort Montolio

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The Life Skills Profile questionnaire (LSP)	This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behavior and autonomous life	Change from Life Skills at 3-6-9 months (12 minutes)
Primary	Barrat impulsiveness scale (BIS-11)	This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained	Change from impulsiveness at 3-6-9 months (12 minutes)
Primary	Calgary Depresión Scale for Schizophrenia (CDSS)	The questionnaire is a structured instrument, administered by a clinician in a hetero-applied way for the adult population, with an approximate administration time of between 10 and 30 minutes, and covers the therapeutic area related to the symptoms of depressive disorders.	Change from Depresión at 3-6-9 months (12 minutes)
Primary	Rosenberg Self-Esteem Scale	The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).	Change from self-esteem at 3-6-9 months (12 minutes)
Primary	Positive and negative symptom scale (PANSS)	It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders	Change from Positive and negative symptom at 3-6-9 months (12 minutes)